Are EU payers adapting Biosimilar Pricing and Reimbursement approval processes to Optimize Healthcare savings?
May 1, 2015, 00:00 AM
10.1016/j.jval.2015.03.516
https://www.valueinhealthjournal.com/article/S1098-3015(15)00573-2/fulltext
Section Title :
Research Poster Presentations - Session II
Section Order :
1619
First Page :
A88
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)00573-2&doi=10.1016/j.jval.2015.03.516